The epidemiology of valvular heart disease: a growing public health problem.
about
Exercise-based cardiac rehabilitation for adults after heart valve surgeryExercise-based cardiac rehabilitation for adults after heart valve surgeryTransforming growth factor Beta2 is required for valve remodeling during heart developmentExtracellular matrix remodeling during the progression of volume overload-induced heart failure.Trends in aortic valve replacement for elderly patients in the United States, 1999-2011.Determinants of clinical improvement after surgical replacement or transcatheter aortic valve implantation for isolated aortic stenosisPatient experiences of recovery after heart valve replacement: suffering weakness, struggling to resume normality.Impact and predictors of noncircular left ventricular outflow tract shapes on estimating aortic stenosis severity by means of continuity equationsTransforming growth factor beta signaling in adult cardiovascular diseases and repair.Drug Therapy for Heart Valve Diseases.Improved costs and outcomes with conscious sedation vs general anesthesia in TAVR patients: Time to wake up?Effect of comprehensive cardiac rehabilitation after heart valve surgery (CopenHeartVR): study protocol for a randomised clinical trial.Imaging in Transcatheter Aortic Valve Replacement (TAVR): role of the radiologist.Mortality prediction in Indian cardiac surgery patients: Validation of European System for Cardiac Operative Risk Evaluation II.Heart valve structure and function in development and diseaseNotch signaling in cardiac valve development and disease.New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review.Aortic stenosis: a general overview of clinical, pathophysiological and therapeutic aspects.Access site bleeding after transcatheter aortic valve implantation.Contemporary strategy for aortic valve stenosis in octogenarians.Transcatheter tissue engineered heart valves.Translational Challenges in Cardiovascular Tissue Engineering.The Impact of Frailty on Patient-Centered Outcomes Following Aortic Valve Replacement.Relapsing Polychondritis Can Be Characterized by Three Different Clinical Phenotypes: Analysis of a Recent Series of 142 Patients.Cardiac rehabilitation patients' perspectives on the recovery following heart valve surgery: a narrative analysis.Availability of, referral to and participation in exercise-based cardiac rehabilitation after heart valve surgery: Results from the national CopenHeart survey.Recent advances in understanding and managing aortic stenosis.nkx genes establish SHF cardiomyocyte progenitors at the arterial pole and pattern the venous pole through Isl1 repression.High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis.Tissue engineered heart valves: moving towards clinical translation.Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis.Cell Sources for Tissue Engineering Strategies to Treat Calcific Valve Disease
P2860
Q24186018-FD6A12AB-DEF1-4429-81BD-B9B88C87D74DQ24202163-D90FB864-2AE4-4B07-AB61-4181F1110D00Q28505676-48BB14F6-D1D6-48EC-8DB4-17C5211096C6Q33665698-AEEBA591-090E-424B-9170-4073AA8D3B50Q33874373-D4B13963-E9B9-4166-9DFF-A3C26AB1BD85Q34340189-B61680E4-CE48-4894-B14F-B614D519244AQ35000165-206047E0-7EA0-44B9-BA0E-DDC9A8DEF016Q35228380-987E885A-EA22-4C39-9716-63D849B7368DQ35895390-A297A6A4-13CC-464A-B7CC-988B24A20F65Q36091454-EB380445-B4B7-4688-A09B-95132FE15F9FQ36335818-5AE33820-2957-4D5A-877D-0E40208D6816Q37108991-A5A42A0F-7F27-41AF-9756-CF03C261A5DDQ37628907-D84F4B43-EADD-4EFF-9138-2D7280D6EC47Q37671351-608771C7-9161-4977-87D5-D086CFAFB66AQ37784511-941F2DC9-AD0E-4ACC-87A2-63186A1B22FBQ37874571-F9CF4BD7-D20B-4856-BEE6-E74115A2AFAFQ37950408-9867C1C0-EFDD-45BD-BCE5-9002538C7EF0Q38081160-C770C93F-C29E-4C2A-9C86-ADBAF36EE10EQ38103787-7B4A4109-551A-45B4-89C9-85151BA3501FQ38121416-F9CEA709-2A6D-45F8-9581-7D4C1D22FFD7Q38168934-C381A878-5B38-4644-8A5D-504157F998EDQ38747713-33849797-8AE1-484A-81CE-24097467425BQ39304953-C5ABB030-1806-4DAF-AAFE-4CB5230A144FQ39664235-A36010AF-C834-40E4-868D-F266C1620D7BQ40073628-A365ACCD-B041-41EF-91BA-4723F581D187Q43535166-507ED426-267C-4B1E-B63D-74C7E6CDB32BQ48155124-613C7992-FF99-41A6-AE76-3264A82C0CC4Q48183264-D3D6F871-B13A-427B-8E05-0EA4476DFEB6Q48540294-C87FAC2B-3D83-4B82-BD82-CBE953EC6DA3Q51387822-9175FB7C-01C4-494F-B61C-9EEA92950F29Q52609535-19C6AA02-087E-4C86-851D-1FE11BCAAC83Q59128332-F33702B4-7168-4343-A43C-3B363BC45F23
P2860
The epidemiology of valvular heart disease: a growing public health problem.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The epidemiology of valvular heart disease: a growing public health problem.
@en
type
label
The epidemiology of valvular heart disease: a growing public health problem.
@en
prefLabel
The epidemiology of valvular heart disease: a growing public health problem.
@en
P2093
P1476
The epidemiology of valvular heart disease: a growing public health problem.
@en
P2093
Abraham Bornstein
Jacek Preibisz
Jeffrey S Borer
Phyllis G Supino
P304
P356
10.1016/J.HFC.2006.09.010
P577
2006-10-01T00:00:00Z